Sort
30,917 grants matching “tumor microenvironment”
Project 5 - EBV Drivers of Oncogenesis and Novel Therapies
$389,908Shannon Celeste Kenney · University Of Wisconsin-Madison · P01 · FY2021 · CA
Tumor Cell Biology Training Program
$389,890Gay Miriam Crooks · University Of California Los Angeles · T32 · FY2013 · CA
An Engineered Tissue Model of Aged Mammary Microenvironment
$389,860Pinar Zorlutuna · University Of Notre Dame · R01 · FY2022 · EB
A NOVEL LINEAGE SPECIFIC METASTASIS PATHWAY IN LUNG CANCER
$389,856Don X Nguyen · Yale University · R01 · FY2023 · CA
A NOVEL LINEAGE SPECIFIC METASTASIS PATHWAY IN LUNG CANCER
$389,856Don X Nguyen · Yale University · R01 · FY2022 · CA
Novel mechanism of chemokine nitration in bladder cancer
$389,848Neelam Mukherjee · University Of Texas Hlth Science Center · R01 · FY2024 · CA
A Quantitative PET/CT Research Resource for Co-Clinical Imaging of Lung Cancer Therapies
$389,775Paul E Kinahan · University Of Washington · U24 · FY2023 · CA
Strategies for Cure in Newly Diagnosed Multiple Myeloma
$389,770Bart Barlogie · Univ Of Arkansas For Med Scis · P01 · FY2013 · CA
Liquid biopsy of the lung to profile lung cancer
$389,670Viswam Siva Nair · Fred Hutchinson Cancer Center · U01 · FY2022 · CA
Liquid biopsy of the lung to profile lung cancer
$389,670Viswam Siva Nair · Fred Hutchinson Cancer Center · U01 · FY2023 · CA
The Role of Lumican in the cornea
$389,664Shukti Chakravarti · Johns Hopkins University · R01 · FY2011 · EY
The Role of Lumican in the cornea
$389,664Shukti Chakravarti · Johns Hopkins University · R01 · FY2012 · EY
Bioengineering approaches to map mechanotransduction in the living cell
$389,659Ning Wang · University Of Illinois At Urbana-Champaign · R01 · FY2019 · GM
Pro-tumor functions of neutrophils in squamous cell lung cancer
$389,613Trudy Gale Oliver · University Of Utah · R01 · FY2021 · CA
Pro-tumor functions of neutrophils in squamous cell lung cancer
$389,613Trudy Gale Oliver · University Of Utah · R01 · FY2020 · CA
INTEGRIN SIGNALING DURING BREAST TUMORIGENESIS
$389,600Filippo G Giancotti · Sloan-Kettering Inst Can Research · R01 · FY2010 · CA
AKT pathway as a therapeutic tumor vessel target
$389,596Laura E Benjamin · Beth Israel Deaconess Medical Center · R01 · FY2008 · CA
Targeting DNA repair to eradicate TKi-refractory/resistant CML and Ph+ALL
$389,557Tomasz Skorski · Temple Univ Of The Commonwealth · R01 · FY2023 · CA
Quantitative assessment of the role of collagen alterations in ovarian cancer
$389,549Paul J. Campagnola · University Of Wisconsin-Madison · R01 · FY2018 · CA
Training Program in Tumor Microenvironment
$389,532Maria G Castro · University Of Michigan At Ann Arbor · T32 · FY2024 · CA
Transport Oncophysics Core
$389,506Haifa Shen · Methodist Hospital Research Institute · U54 · FY2019 · CA
Project 2: Optimal Targeting of the PD-1/PD-L1 Pathway in MRCC
$389,502Catherine Ju-Ying Wu · Beth Israel Deaconess Medical Center · P50 · FY2024 · CA
Targeting the vasculature to enhance anti-tumor immunity
$389,460Andrew Carl Dudley · University Of Virginia · R01 · FY2023 · CA
Bioengineering approaches to map mechanotransduction in the living cell
$389,454Ning Wang · University Of Illinois At Urbana-Champaign · R01 · FY2020 · GM
The Inhibition of HNSCC Growth and Metastasis by Targeting KDM4A
$389,423Cun-Yu Wang · University Of California Los Angeles · R01 · FY2024 · DE